SureTrader Nadex Advertisement PGUS
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 3/24/2017 3:30:52 AM - Followers: 1318 - Board type: Free - Posts Today: 3

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#210082  Sticky Note Pieris: Strongly suggest listening to the quarterly. Stephen gdollasign 03/23/17 05:42:11 PM
#210076  Sticky Note FDA’s acceptance of the Durvalumab BLA on 12/9/16 genisi 03/23/17 04:40:26 PM
#210073  Sticky Note I-O MoAs genisi 03/23/17 04:35:51 PM
#210068  Sticky Note PFE/Merck-KGaA—FDA approves Bavencio (avelumab) for Merkel cell carcinoma: DewDiligence 03/23/17 03:02:12 PM
#210055  Sticky Note FLXN +19% on SNY-buyout chatter: DewDiligence 03/23/17 10:30:17 AM
#210037  Sticky Note Rare Discovery: A Value in the Biotech World jbog 03/22/17 01:16:45 PM
#210094   MedImmune Vaccines (formerly Aviron) has submitted the first genisi 03/24/17 03:30:52 AM
#210093   hi my friend, good evening. i like your mick 03/24/17 01:34:38 AM
#210092   TYMI FreeNorth 03/24/17 01:18:53 AM
#210091   >> It's the first BLA in AZN's corporate jq1234 03/23/17 10:20:07 PM
#210090   BLCM sells 5.75M* shares @$12.00—a 16.5% discount to DewDiligence 03/23/17 07:54:25 PM
#210089   My own form of 'quiz for the day'. north40000 03/23/17 06:27:28 PM
#210088   What are you referring to, specifically? DewDiligence 03/23/17 06:25:01 PM
#210087   "the first BLA in AZN's corporate history!!" north40000 03/23/17 06:22:11 PM
#210086   So, similar US list price to other PD-(L)1 drugs. DewDiligence 03/23/17 06:22:08 PM
#210085   Popular treatment price...$13k/month, per Bloomberg. north40000 03/23/17 06:17:56 PM
#210084   RXDX less interested in Taladegib than it once was: DewDiligence 03/23/17 06:15:12 PM
#210083   If you search clinicaltrials.gov you'll find quite few genisi 03/23/17 05:49:20 PM
#210082   Pieris: Strongly suggest listening to the quarterly. Stephen gdollasign 03/23/17 05:42:11 PM
#210081   Yes, but they haven't (yet) pursued a similar JohnWayne 03/23/17 05:12:37 PM
#210080   lower dose than for CTLA-4 in other tumor genisi 03/23/17 04:56:26 PM
#210079   No, not following AZN that close but someone genisi 03/23/17 04:48:47 PM
#210078   Bingo! It's the first BLA in AZN's corporate history!! DewDiligence 03/23/17 04:44:53 PM
#210077   If I was invested in AZN, I would DewDiligence 03/23/17 04:42:55 PM
#210076   FDA’s acceptance of the Durvalumab BLA on 12/9/16 genisi 03/23/17 04:40:26 PM
#210075   Yes, in effect that's what my 2nd answer JohnWayne 03/23/17 04:38:54 PM
#210074   Thanks, Idit. That explanation is indeed more scientific DewDiligence 03/23/17 04:38:37 PM
#210073   I-O MoAs genisi 03/23/17 04:35:51 PM
#210072   I'll give you atypical based on the timing. WorstLuck 03/23/17 03:43:03 PM
#210071   New quiz: AZN—Very weird to halt a Big DewDiligence 03/23/17 03:25:30 PM
#210070   In this instance, the major shareholders added at DewDiligence 03/23/17 03:18:43 PM
#210069   So in this case a Form 4 (buy WorstLuck 03/23/17 03:14:42 PM
#210068   PFE/Merck-KGaA—FDA approves Bavencio (avelumab) for Merkel cell carcinoma: DewDiligence 03/23/17 03:02:12 PM
#210067   I talk to biotech journalists pretty often, but DewDiligence 03/23/17 02:44:56 PM
#210066   If we're counting all sources for such rumors, DewDiligence 03/23/17 02:42:16 PM
#210065   You should talk to journalists more often. LOL lgonber 03/23/17 01:13:08 PM
#210064   in your experience, how often are these rumors jellybean 03/23/17 01:09:31 PM
#210063   ENTA +5%. Biotech investors read the WSJ, evidently. DewDiligence 03/23/17 12:49:23 PM
#210062   Re: Quiz answer /I-O MoAs …answer is DewDiligence 03/23/17 12:45:20 PM
#210061   Hmmm, full answer is proving more difficult to JohnWayne 03/23/17 12:30:56 PM
#210060   Yikes, even more than thousands of fake open swampboots 03/23/17 12:06:10 PM
#210059   CARA Dew , this trial is Whalatane 03/23/17 11:50:37 AM
#210058   GLMD had only $12.2M net current assets at DewDiligence 03/23/17 11:09:27 AM
#210057   ADXS plans to submit 2H17 MAA for AXAL DewDiligence 03/23/17 11:01:00 AM
#210056   You beat me to the post w/ same puravida 03/23/17 10:39:40 AM
#210055   FLXN +19% on SNY-buyout chatter: DewDiligence 03/23/17 10:30:17 AM
#210054   Good point re GILD's executives (eom). DewDiligence 03/23/17 10:19:00 AM
#210053   HTBX sells 5.75M* shares @$0.80—a 22% discount to DewDiligence 03/23/17 10:17:19 AM
#210052   I feel it's more important to see what jbog 03/23/17 10:17:19 AM
#210051   TNDM -18% on sale of 20.7M* shares @$1.25—a DewDiligence 03/23/17 10:05:25 AM
#210050   LJPC sells 4.26M* shares @$33.50—a 13% discount to DewDiligence 03/23/17 09:54:26 AM
#210049   I generally wouldn't be more likely to short DewDiligence 03/23/17 09:48:25 AM
#210048   To clarify - would a 10b-5-1 sale have WorstLuck 03/23/17 09:42:55 AM
#210047   That's not a full quiz answer. What is DewDiligence 03/23/17 09:34:51 AM
#210046   Standard dosing cycle for CTLA-4 inhibitor. True not JohnWayne 03/23/17 12:14:08 AM
#210045   It didn't fit your style to short that WorstLuck 03/22/17 09:37:16 PM
PostSubject